Symbol="VYGR"
AssetType="Common Stock"
Name="Voyager Therapeutics Inc"
Description="Voyager Therapeutics, Inc., a clinical-stage gene therapy company, is focused on developing treatments for patients with severe neurological diseases. The company is headquartered in Cambridge, Massachusetts."
CIK="1640266"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="75 SIDNEY STREET, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="401398000"
EBITDA="91673000"
PERatio="4.191"
PEGRatio="0"
BookValue="4.548"
DividendPerShare="0"
DividendYield="0"
EPS="2.2"
RevenuePerShareTTM="4.834"
ProfitMargin="0.492"
OperatingMarginTTM="0.448"
ReturnOnAssetsTTM="0.217"
ReturnOnEquityTTM="0.74"
RevenueTTM="194869000"
GrossProfitTTM="-19857000"
DilutedEPSTTM="2.2"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="5.82"
AnalystTargetPrice="13.67"
TrailingPE="4.191"
ForwardPE="-"
PriceToSalesRatioTTM="3.271"
PriceToBookRatio="2.825"
EVToRevenue="1.667"
EVToEBITDA="-8.56"
Beta="1.06"
num_52WeekHigh="14.34"
num_52WeekLow="4.77"
num_50DayMovingAverage="10.49"
num_200DayMovingAverage="8.44"
SharesOutstanding="43535600"
DividendDate="None"
ExDividendDate="None"
symbol="VYGR"
open="9.00"
high="9.41"
low="8.81"
price="9.31"
volume="342871.00"
latest_trading_day="2023-08-18"
previous_close="9.09"
change="0.22"
change_percent="2.4202%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="33"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="67"
Volume_recent_avg="526110"
Change_recent_avg="0.02"
Delta_recent_avg="0.59"
Variance_recent_avg="0.3"
Change_ratio_recent_avg="0.16"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_negative_10"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="67"
Aroon_momentum_negative="33"
image_negative_thumbnail_id_1="132"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0044.jpeg"
image_negative_thumbnail_id_2="497"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0108.jpeg"
image_neutral_thumbnail_id_1="581"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0018.jpeg"
image_neutral_thumbnail_id_2="524"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0075.jpeg"
image_positive_thumbnail_id_1="688"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0020.jpeg"
image_positive_thumbnail_id_2="646"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0062.jpeg"
image_professor_thumbnail_id_1="1181"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
image_professor_thumbnail_id_2="1183"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
